{"entity":{"type":"insider","cik":"0001780660","url":"/insider/0001780660","json_url":"/insider/0001780660.json","name":"LO FRANCIS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":30,"first":"2020-01-07","last":"2026-07-17","span_basis":"filed_date"},"name_variants":[{"name":"LO FRANCIS","source":"filing","n_filings":30,"first_seen":"2020-01-07","last_seen":"2026-07-17"}],"transactions":[{"id":5758817,"accession":"0001780660-26-000019","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780660-26-000019","line_url":"/filing/0001780660-26-000019#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105762.0,"shares_display":"105,762","price_per_share":22.59,"price_display":"22.59","price_state":"stated","total_value":2389163.58,"total_display":"2,389,163.58","total_whole":"2,389,164","shares_owned_after":230713.0,"shares_owned_after_display":"230,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-17","scope":"insider"},{"id":6061767,"accession":"0001780660-26-000017","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001780660-26-000017","line_url":"/filing/0001780660-26-000017#line-11","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44838.0,"shares_display":"44,838","price_per_share":22.59,"price_display":"22.59","price_state":"stated","total_value":1012890.42,"total_display":"1,012,890.42","total_whole":"1,012,890","shares_owned_after":230713.0,"shares_owned_after_display":"230,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-02","filed_date":"2026-07-06","scope":"insider"},{"id":6061757,"accession":"0001780660-26-000017","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001780660-26-000017","line_url":"/filing/0001780660-26-000017","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51004.0,"shares_display":"51,004","price_per_share":22.445146263038193,"price_display":"22.45","price_state":"stated","total_value":1144792.24,"total_display":"1,144,792.24","total_whole":"1,144,792","shares_owned_after":237688.0,"shares_owned_after_display":"237,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-06","scope":"insider","n_lines":2},{"id":5949680,"accession":"0001780660-26-000015","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001780660-26-000015","line_url":"/filing/0001780660-26-000015#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39741.0,"shares_display":"39,741","price_per_share":17.49,"price_display":"17.49","price_state":"stated","total_value":695070.09,"total_display":"695,070.09","total_whole":"695,070","shares_owned_after":250934.0,"shares_owned_after_display":"250,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-08","scope":"insider"},{"id":5989501,"accession":"0001780660-26-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780660-26-000013","line_url":"/filing/0001780660-26-000013#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22564.0,"shares_display":"22,564","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":340039.48,"total_display":"340,039.48","total_whole":"340,039","shares_owned_after":271154.0,"shares_owned_after_display":"271,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-10","scope":"insider"},{"id":5911384,"accession":"0001780660-26-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780660-26-000011","line_url":"/filing/0001780660-26-000011#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30593.0,"shares_display":"30,593","price_per_share":14.08,"price_display":"14.08","price_state":"stated","total_value":430749.44,"total_display":"430,749.44","total_whole":"430,749","shares_owned_after":291374.0,"shares_owned_after_display":"291,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-13","scope":"insider"},{"id":5949667,"accession":"0001780660-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780660-26-000007","line_url":"/filing/0001780660-26-000007#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38074.0,"shares_display":"38,074","price_per_share":15.09,"price_display":"15.09","price_state":"stated","total_value":574536.66,"total_display":"574,536.66","total_whole":"574,537","shares_owned_after":321967.0,"shares_owned_after_display":"321,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider"},{"id":5969686,"accession":"0001780660-26-000003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001780660-26-000003","line_url":"/filing/0001780660-26-000003#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79590.0,"shares_display":"79,590","price_per_share":17.73,"price_display":"17.73","price_state":"stated","total_value":1411130.7,"total_display":"1,411,130.70","total_whole":"1,411,131","shares_owned_after":315978.0,"shares_owned_after_display":"315,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6061739,"accession":"0001780660-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780660-26-000001","line_url":"/filing/0001780660-26-000001#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3125.0,"shares_display":"3,125","price_per_share":16.08,"price_display":"16.08","price_state":"stated","total_value":50250.0,"total_display":"50,250.00","total_whole":"50,250","shares_owned_after":315978.0,"shares_owned_after_display":"315,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":9295912,"accession":"0001780660-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780660-26-000002","line_url":"/filing/0001780660-26-000002#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4394.0,"shares_display":"4,394","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":76895.0,"total_display":"76,895.00","total_whole":"76,895","shares_owned_after":315978.0,"shares_owned_after_display":"315,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2026-01-07","scope":"insider"},{"id":4440576,"accession":"0001780660-25-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780660-25-000003","line_url":"/filing/0001780660-25-000003#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4394.0,"shares_display":"4,394","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":76895.0,"total_display":"76,895.00","total_whole":"76,895","shares_owned_after":315978.0,"shares_owned_after_display":"315,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-29","scope":"insider"},{"id":4777866,"accession":"0001780660-25-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780660-25-000002","line_url":"/filing/0001780660-25-000002#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":113890.0,"shares_display":"113,890","price_per_share":15.57,"price_display":"15.57","price_state":"stated","total_value":1773267.3,"total_display":"1,773,267.30","total_whole":"1,773,267","shares_owned_after":315978.0,"shares_owned_after_display":"315,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-17","scope":"insider"},{"id":5199619,"accession":"0001062993-25-004818","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-25-004818","line_url":"/filing/0001062993-25-004818","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20875.0,"shares_display":"20,875","price_per_share":6.986605988023952,"price_display":"6.99","price_state":"stated","total_value":145845.4,"total_display":"145,845.40","total_whole":"145,845","shares_owned_after":332846.0,"shares_owned_after_display":"332,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider","n_lines":2},{"id":2469629,"accession":"0001062993-24-005763","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-24-005763","line_url":"/filing/0001062993-24-005763","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14700.0,"shares_display":"14,700","price_per_share":3.431233333333333,"price_display":"3.43","price_state":"stated","total_value":50439.13,"total_display":"50,439.13","total_whole":"50,439","shares_owned_after":255558.0,"shares_owned_after_display":"255,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider","n_lines":2},{"id":8197042,"accession":"0001062993-23-006329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-006329","line_url":"/filing/0001062993-23-006329#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6816.0,"shares_display":"6,816","price_per_share":8.57,"price_display":"8.57","price_state":"stated","total_value":58413.12,"total_display":"58,413.12","total_whole":"58,413","shares_owned_after":168469.0,"shares_owned_after_display":"168,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":6121102,"accession":"0001209191-22-017839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-017839","line_url":"/filing/0001209191-22-017839#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3582.0,"shares_display":"3,582","price_per_share":11.44,"price_display":"11.44","price_state":"stated","total_value":40978.08,"total_display":"40,978.08","total_whole":"40,978","shares_owned_after":89588.0,"shares_owned_after_display":"89,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-10","scope":"insider"},{"id":6668500,"accession":"0001209191-22-017395","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017395","line_url":"/filing/0001209191-22-017395#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1569.0,"shares_display":"1,569","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":18843.69,"total_display":"18,843.69","total_whole":"18,844","shares_owned_after":93170.0,"shares_owned_after_display":"93,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":5380237,"accession":"0001209191-21-033313","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-033313","line_url":"/filing/0001209191-21-033313#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":33.8,"price_display":"33.80","price_state":"stated","total_value":67600.0,"total_display":"67,600.00","total_whole":"67,600","shares_owned_after":20604.0,"shares_owned_after_display":"20,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-17","scope":"insider"},{"id":4272231,"accession":"0001209191-21-027122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-027122","line_url":"/filing/0001209191-21-027122#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":43.04,"price_display":"43.04","price_state":"stated","total_value":86080.0,"total_display":"86,080.00","total_whole":"86,080","shares_owned_after":20604.0,"shares_owned_after_display":"20,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-16","scope":"insider"},{"id":4824007,"accession":"0001209191-21-021549","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-021549","line_url":"/filing/0001209191-21-021549","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":41.82806,"price_display":"41.83","price_state":"stated","total_value":83656.12,"total_display":"83,656.12","total_whole":"83,656","shares_owned_after":20604.0,"shares_owned_after_display":"20,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider","n_lines":2},{"id":5520121,"accession":"0001209191-21-011555","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-011555","line_url":"/filing/0001209191-21-011555#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":65.45,"price_display":"65.45","price_state":"stated","total_value":130900.0,"total_display":"130,900.00","total_whole":"130,900","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":4611942,"accession":"0001209191-21-004519","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-004519","line_url":"/filing/0001209191-21-004519","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":66.54735,"price_display":"66.55","price_state":"stated","total_value":133094.7,"total_display":"133,094.70","total_whole":"133,095","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-20","scope":"insider","n_lines":2},{"id":2560900,"accession":"0001209191-20-063931","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-063931","line_url":"/filing/0001209191-20-063931","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":55.93701,"price_display":"55.94","price_state":"stated","total_value":111874.02,"total_display":"111,874.02","total_whole":"111,874","shares_owned_after":241.0,"shares_owned_after_display":"241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider","n_lines":2},{"id":2445615,"accession":"0001209191-20-059292","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-059292","line_url":"/filing/0001209191-20-059292","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":47.67552,"price_display":"47.68","price_state":"stated","total_value":95351.04,"total_display":"95,351.04","total_whole":"95,351","shares_owned_after":304.0,"shares_owned_after_display":"304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider","n_lines":2},{"id":2444542,"accession":"0001209191-20-055071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-055071","line_url":"/filing/0001209191-20-055071#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":51.51,"price_display":"51.51","price_state":"stated","total_value":103020.0,"total_display":"103,020.00","total_whole":"103,020","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider"},{"id":2225072,"accession":"0001209191-20-054848","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-054848","line_url":"/filing/0001209191-20-054848#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":52.8,"price_display":"52.80","price_state":"stated","total_value":1320000.0,"total_display":"1,320,000.00","total_whole":"1,320,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-14","scope":"insider"},{"id":2191986,"accession":"0001209191-20-050779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050779","line_url":"/filing/0001209191-20-050779#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":42.58,"price_display":"42.58","price_state":"stated","total_value":85160.0,"total_display":"85,160.00","total_whole":"85,160","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-16","scope":"insider"},{"id":2784406,"accession":"0001209191-20-047643","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-047643","line_url":"/filing/0001209191-20-047643","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":39.36245,"price_display":"39.36","price_state":"stated","total_value":78724.9,"total_display":"78,724.90","total_whole":"78,725","shares_owned_after":561.0,"shares_owned_after_display":"561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider","n_lines":2},{"id":3090178,"accession":"0001209191-20-043012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-043012","line_url":"/filing/0001209191-20-043012","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":43.855,"price_display":"43.86","price_state":"stated","total_value":87710.0,"total_display":"87,710.00","total_whole":"87,710","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider","n_lines":2},{"id":2338414,"accession":"0001209191-20-038075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038075","line_url":"/filing/0001209191-20-038075#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":44.34,"price_display":"44.34","price_state":"stated","total_value":88680.0,"total_display":"88,680.00","total_whole":"88,680","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-19","scope":"insider"},{"id":3013401,"accession":"0001209191-20-002420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002420","line_url":"/filing/0001209191-20-002420#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780660","owner_name":"LO FRANCIS","owner_display_name":"LO FRANCIS","owner_url":"/insider/0001780660","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2020-01-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":39,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Officer (Chief People Officer)","n_filings":30,"first_seen":"2020-01-07","last_seen":"2026-07-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780660","retrieved_at":"2026-08-26T04:33:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}